New tool combining evolution and AI predicts prostate cancer recurrence more than a decade ahead 11 Jul 2024 Combining the principles of evolution with artificial intelligence (AI), scientists have proposed a new way to predict the chance of prostate cancer returning. In a recent study, they harnessed computational methods to capture specific tumour measurements relating to the tumour’s ability to change over time. They then showed that these measurements correlate with disease recurrence more than a decade after the initial diagnosis. Find out more Show/Hide
Artificial Intelligence reveals prostate cancer is not just one disease 29 Feb 2024 Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future. Find out more Show/Hide
New AI collaboration could advance precision therapy in breast cancer 09 Feb 2024 A new collaboration between academic and industry researchers could help to improve clinical decision making for cancer patients – including by potentially guiding the use of immunotherapy to breast cancer patients who could benefit from it. Find out more Show/Hide
England’s first Integrated Pathology Unit focusing on clinical trial research will use novel technology to diagnose cancer faster and more affordably 11 May 2023
AI study 'exciting first step' towards improving post-treatment surveillance of lung cancer patients 23 Apr 2022
ICR researchers reveal how they are tackling rare cancers at virtual Discovery Club event 09 Jun 2021